Angus C. Russell, Director at TherapeuticsMD, Inc. (TXMD), bought 35,000 shares at $2.76 ($99K) on 2019-08-14, disclosed to the SEC on 2019-08-15.
Open-market purchase of $99k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.76 | 25,000 | $69K | 69.8% |
| 2 | $2.99 | 10,000 | $30K | 30.2% |
| Total | $2.83 avg | 35,000 | $99K | 100% |
| Filing → |
| MNKKQ | SELL | 2020-11-16 | $7K | — | Filing → |
| TXMD | BUY | 2019-08-26 | $28K | — | Filing → |
| BTX | BUY | 2015-11-10 | $192K | — | Filing → |